Curative Biotechnology Inc (CUBT)

[trader59]

You won’t get the S-1 cancelled, and without it the company will have to take on convertible notes, or do the RS anyway and sell stock, or be dead. They have no cash, have a $2M debt hanging over their heads, and have made zero progress since the first offering/RS/uplist failed. That first S-1 wreaked of a company looking to pile up some cash to pay themselves for a few years, and this latest version only commits to spending $2M of the $7M raised on the drug (with $2M paying debt and the rest uncommitted).